Overview Welcome to Dechra Pharmaceuticals PLC Growing Our Geographical Footprint Dechra's Strengths Highlights Chairman's View Strategic Report Our Marketplace Global Market Dynamics Product Market Dynamics Our Business Model Creating Value for Our Stakeholders Delivering Our Strategy Overview Strategic Timeline Our Achievements and Progress Chief Executive Officer's Statement Q&A with Ian Page Financial Review Key Performance Indicators Strategy in Action Pipeline Delivery Portfolio Focus Geographical Expansion Product Development Product Development Process Product Development Pipeline International Product Offering Corporate Social Responsibility Overview Our People Our Community Our Environment Our Business How the Business Manages Risk Overview Understanding Our Key Risks Governance Letter from the Chairman on Governance Compliance with the Code Corporate Governance Board Senior Executive Team Leadership Effectiveness Accountability Relations with Shareholders Audit Committee Report Letter from the Audit Committee Chairman Audit Committee Report Nomination Committee Report Letter from the Nomination Committee Chairman Nomination Committee Report Director's Remuneration Report Letter from the Remuneration Committee Chairman Remuneration at a Glance 2019 Annual Report on Remuneration Directors' Remuneration Policy Directors' Report - Other Disclosures Statement of Directors' Responsibilities Financial Statements Independent Auditors' Report to the Members of Dechra Pharmaceuticals PLC Consolidated Income Statement Consolidated Statement of Comprehensive Income Consolidated Statement of Financial Position Consolidated Statement of Changes in Shareholders' Equity Consolidated Statement of Cash Flows Notes to the Consolidated Financial Statements Company Statement of Financial Position Company Statement of Changes in Shareholders' Equity Notes to the Company Financial Statements Financial History Company Information Glossary Shareholder Information Advisers